IMRT or 3D-CRT in glioblastoma? A dosimetric criterion for patient selection

Technology in Cancer Research and Treatment

Volumn 12, Issue 5, 2013, Pages 411-420

  Lorentini, S ^a   Amelio, D ^a,b   Giri, M G ^c   Fellin, F ^a,b   Meliado G ^c   Rizzotti, A ^c   Amichetti, M ^a,b   Schwarz, M ^a,b  

^a Agenzia Provinciale per la Protonterapia   (Italy)

^b Azienda Provinciale per i Servizi Sanitari   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Conformal radiation therapy; Glioblastoma multiforme; Intensity modulated radiation therapy; PTV OAR overlap; Selection criteria

Indexed keywords

ARTICLE; BRAIN RADIATION; BRAIN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; GLIOBLASTOMA; HISTOGRAM; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANS AT RISK; PATIENT SELECTION; RADIATION DOSE; RADIATION DOSE REDUCTION; TREATMENT PLANNING; TUMOR VOLUME; ADJUVANT THERAPY; BRAIN NEOPLASMS; BRAIN STEM; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; OPTIC CHIASM; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE;

BRAIN NEOPLASMS; BRAIN STEM; DECISION SUPPORT TECHNIQUES; DOSE FRACTIONATION; GLIOBLASTOMA; HUMANS; OPTIC CHIASM; ORGANS AT RISK; PATIENT SELECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84884139125     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500341     Document Type: Article

References (27)

1. Stupp, R., Hegi, M. E., Gilbert, M. R., Chakravarti, A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25, 4127-4136 (2007). DOI: 10.1200/ JCO.2007.11.8554
2. Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., et al. European organisation for research and treatment of cancer brain tumor and radiation oncology groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10, 459-466 (2009). DOI: 10.1016/S1470-2045(09)70025-7
3. Ataman, F., Poortmans, P., Stupp, R., Fisher, B., Mirimanoff, R. O. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review. Eur J Cancer 40, 1724-1730 (2004). DOI: 10.1016/j.ejca.2004.03.026
4. Amelio, D., Lorentini, S., Schwarz, M., Amichetti, M. Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. Radiother Oncol 97, 361-369 (2010). DOI: 10.1016/j.radonc.2010.08.018
5. Farace, P., Giri, M. G., Meliadò, G, Amelio, D., Widesott, L., Ricciardi, G. K., Dall'Oglio, S., Rizzotti, A., Sbarbati, A., Beltramello, A., Maluta, S., Amichetti, M. Clinical target volume delineation in glioblastoma: pre-operative versus post-operative/pre-radiotherapy MRI. Br J Radiol 84, 271-278 (2011). DOI: 10.1259/ bjr/10315979
6. Alber, M., Birkner, M., Laub, W., Nüsslin, F. Hyperion - an integrated IMRT planning tool. In: Schlegel, W., Bortfeld, T. (Eds.). Proceedings of 13th International Conference on the Use of Computers in Radiation Therapy. Heidelberg: Springer 46-48 (2000).
7. Jelen, U., Alber, M. A finite size pencil beam algorithm for IMRT dose optimization: density corrections. Phys Med Biol 52, 617-633 (2007). DOI: 10.1088/0031-9155/52/3/006
8. Thilmann, C., Zabel, A., Grosser, K. H., Hoess, A., Wannenmacher, M., Debus, J. Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer 96, 341-349 (2001). DOI: 10.1002/ijc.1042
9. MacDonald, S. M., Ahmad, S., Kachris, S., Vogds, B. J., DeRouen, M., Gittleman, A. E., DeWyngaert, K., Vlachaki, M. T. Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison. J Appl Clin Med Phys 8, 47-60 (2007). MEDL:17592465#105482
10. Wagner, D., Christiansen, H., Wolff, H., Vorwerk, H. Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol 93, 593-596 (2009). DOI:10.1016/ j.radonc.2009.10.002
11. Shaffer, R., Nichol, A. M., Vollans, E., Fong, M., Nakano, S., Moiseenko, V., Schmuland, M., Ma, R., McKenzie, M., Otto, K. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys 76, 1177-1184 (2010). DOI: 10.1016/j.ijrobp.2009.03.013
12. Hermanto, U., Frija, E. K., Lii, M. J., Chang, E. L., Mahajan, A., Woo, S. Y. Intensity modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 67, 1135-1144 (2007). DOI: 10.1016/ j.ijrobp.2006.10.032
13. Narayana, A., Yamada, J., Berry, S., Shah, P., Hunt, M., Gutin, P. H., Leibel, S. A. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetrical results. Int J Radiat Oncol Biol Phys 64, 892-897 (2006). DOI: 10.1016/j.ijrobp.2005.05.067
14. Chan, M. F., Schupak, K., Burman, C., Chui, C. S., Ling, C. C. Comparison of intensity modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme. Med Dosim 28, 261-265 (2003). DOI: 10.1016/j. meddos.2003.08.004
15. Zach, L., Stall, B., Ning, H., Ondos J., Arora B., Uma, S., Miller, R. W., Citrin, D., Camphausen, K. A dosimetric comparison of four treatment planning methods for high grade glioma. Radiat Oncol 4, 45 (2009). DOI: 10.1186/1748-717X-4-45
16. Piroth, M. D., Pinkawa, M., Holy, R., Stoffels, G., Demirel, C., Attieh, C., Kaiser, H. J., Langen, K. J., Eble, M. J. Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme - a dosimetric comparison. Radiat Oncol 4, 57 (2009). DOI: 10.1186/1748-717X-4-57
17. Minniti, G., Amelio, D., Amichetti, M., Salvati, M., Muni, R., Bozzao, A., Lanzetta, G., Scarpino, S., Arcella, A., Enrici, R. M. Patterns of failure and comparison of different target volume delineation in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 97, 377-381 (2010). DOI: 10.1016/j.radonc.2010.08.020
18. Lawrence, Y. R., Li, X. A., El Naqa, I., Hahn, C. A., Marks, L. B., Merchant, T. E., Dicker, A. P. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76, S20-27 (2010). DOI: 10.1016/ j.ijrobp.2009.02.091
19. Johannesen, T. B., Lien, H. H., Hole, K. H., Lote, K. Radiological and clinical assessment of long-term brain tumor survivors after radiotherapy. Radiother Oncol 69, 169-176 (2003). DOI: 10.1016/ S0167-8140(03)00192-0
20. Steen, R. G., Spence, D., Wu, S., Xiong, X., Kun, L. E., Merchant, T. E. Effect of the therapeutic ionizing radiation on the human brain. Ann Neurol 50, 787-795 (2001). DOI: 10.1002/ana.10029
21. Hottinger, A. F., Yoon, H., DeAngelis, L. M., Abrey, L. E. Neurological outcome of long-term glioblastoma survivors. J Neurooncol 95, 301-305 (2009). DOI: 10.1007/s11060-009-9946-9
22. Lawrence, Y. R., Shi, W., Dicker, A. P. From survival to survivorship: late side effects become an issue in high-grade glioma. Expert Rev Neurother 10, 1493-1495 (2010). DOI: 10.1586/ern.10.123
23. Berens, M. E., Giese, A. "Those left behind." Biology and oncology of invasive glioma cells. Neoplasia 1, 208-219 (1999). PMCID:PMC1508082
24. Mangiola, A., De Bonis, P., Maira, G., Calducci, M., Sica, G., Lama, G., Lauriola, L., Anile, C. Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer 113, 841-846 (2008). DOI: 10.1002/cncr.23624
25. Gerstner, E. R., Sorensen, A. G., Jain, R. K., Batchelor, T. T. Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas. Curr Opin Neurol 21, 728-735 (2008). DOI: 10.1097/WCO.0b013e328318402a.
26. Narayana, A., Chang, J., Thakur, S., Huang, W., Karimi, S., Hou, B., Kowalski, A., Perera, G., Holodny, A., Gutin, P. H. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 80, 347-354 (2007). DOI: 10.1259/ bjr/65349468
27. Jena, R., Price, S. J., Baker, C., Jefferies, S. J., Pickard, J. D., Gillard, J. H., Burnet, N. G. Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma. Clin Oncol 19, 509-516 (2005). DOI: 10.1016/ j.clon.2005.04.012